↓ Skip to main content

Dapagliflozin in patients with COVID-19: truth or dare

Overview of attention for article published in The Lancet Diabetes & Endocrinology, September 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
24 tweeters
facebook
1 Facebook page

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dapagliflozin in patients with COVID-19: truth or dare
Published in
The Lancet Diabetes & Endocrinology, September 2021
DOI 10.1016/s2213-8587(21)00206-0
Pubmed ID
Authors

Xavier Rossello, Francisca Caimari

Twitter Demographics

The data shown below were collected from the profiles of 24 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Librarian 1 33%
Other 1 33%
Unknown 1 33%
Readers by discipline Count As %
Social Sciences 1 33%
Medicine and Dentistry 1 33%
Unknown 1 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2021.
All research outputs
#2,187,505
of 19,148,527 outputs
Outputs from The Lancet Diabetes & Endocrinology
#932
of 1,689 outputs
Outputs of similar age
#51,110
of 335,294 outputs
Outputs of similar age from The Lancet Diabetes & Endocrinology
#27
of 38 outputs
Altmetric has tracked 19,148,527 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,689 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 64.9. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 335,294 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.